Celltrion, Inc. (KRX:068270)
South Korea · Delayed Price · Currency is KRW 175,800
+100 (0.06%)
At close: Jul 16, 2026
Celltrion Market Cap
Celltrion has a market cap or net worth of 40.32 trillion as of July 17, 2026. Its market cap has increased by 2.21% in one year.
Market Cap
40.32T
Enterprise Value
42.91T
Revenue
4.47T
Ranking
n/a
PE Ratio
32.05
Stock Price
175,800.00
ChartMarket Cap Chart
Since August 20, 2008, Celltrion's market cap has increased from 103.80B to 40.32T, an increase of 38,738.60%. That is a compound annual growth rate of 39.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2026 | 40.32T | 1.80% |
| Dec 30, 2025 | 39.60T | -1.89% |
| Dec 30, 2024 | 40.37T | 44.32% |
| Dec 28, 2023 | 27.97T | 21.61% |
| Dec 29, 2022 | 23.00T | -16.64% |
| Dec 30, 2021 | 27.59T | -43.68% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 64.62T |
| ALTEOGEN | 14.81T |
| Samsung Epis Holdings | 9.85T |
| SK Biopharmaceuticals | 6.22T |
| Kolon TissueGene | 5.28T |
| HLB Co., Ltd. | 4.69T |
| LigaChem Biosciences | 3.82T |
| D&D Pharmatech | 3.15T |